Canna~Fangled Abstracts Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors Journal List Int J Mol Sci PMC10094507 As a library, NLM provides access to scientific…Freedom WaresApril 23, 2023
Canna~Fangled Abstracts Cannabinoids and Chronic Liver Diseases Review Int J Mol Sci. 2022 Aug 20;23(16):9423. doi: 10.3390/ijms23169423. Ralph-Sydney Mboumba Bouassa 1 2, Giada Sebastiani 2 3 4, Vincenzo Di…Freedom WaresAugust 20, 2022
Canna~Fangled Abstracts Protective Effects of ( E)-β-Caryophyllene (BCP) in Chronic Inflammation Review Nutrients. 2020 Oct 26;12(11):E3273. doi: 10.3390/nu12113273. Rosaria Scandiffio 1 2, Federica Geddo 1, Erika Cottone 1, Giulia Querio 1, Susanna Antoniotti 1, Maria Pia Gallo 1, Massimo…Freedom WaresOctober 26, 2020
Canna~Fangled Abstracts Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research Editorial Fabienne Marcellin, Hélène Fontaine, Lawrence Serfaty, Philippe Sogni & Maria Patrizia Carrieri Received 22…Freedom WaresMay 9, 2018
Canna~Fangled Abstracts Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH). J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12797. Nordmann S1,2, Vilotitch A1,2, Roux P1,2, Esterle…Freedom WaresOctober 6, 2017
Canna~Fangled Abstracts Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. Br J Pharmacol. 2017 Jan 20. doi: 10.1111/bph.13722. Varga ZV1, Matyas C1, Erdelyi K1, Cinar R2, Nieri D3, Chicca A3, Nemeth BT1, Paloczi…Freedom WaresJanuary 20, 2017
Canna~Fangled Abstracts Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increasing of autophagy. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increasing…Freedom WaresJanuary 9, 2014
Canna~Fangled Abstracts The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Br J Pharmacol. 2011 August; 163(7): 1432–1440. doi: 10.1111/j.1476-5381.2011.01397.x PMCID: PMC3165953 The endocannabinoid system as a key mediator during…Freedom WaresSeptember 9, 2013
Canna~Fangled Abstracts Cannabinoid signaling and liver therapeutics. Cannabinoid signaling and liver therapeutics. Mallat A, Teixeira-Clerc F, Lotersztajn S. Source INSERM, U955, Créteil, 94000, France;…Freedom WaresApril 18, 2013